Is AMS Polymers overvalued or undervalued?

As of 3 September 2025, the valuation grade for AMS Polymers has moved from very attractive to risky. This indicates a shift in perception regarding the company's financial health and market position. The company is currently assessed as overvalued, particularly when compared to its peers in the specialty chemicals industry. Key ratios include a PE ratio of 5.99, an EV to EBITDA of 8.09, and a ROE of 37.07%, which, while seemingly strong, do not align favorably with the overall market sentiment. When compared to peers, AMS Polymers' valuation metrics stand out unfavorably; for instance, Bajaj Finance has a PE ratio of 32.03, and Life Insurance boasts a PE of 11.31, highlighting the disparity in market expectations. Additionally, the company's recent stock performance has lagged behind the Sensex, particularly over the longer term, with a 5-year return of 27.26% compared to the Sensex's 106.63%. This further reinforces the notion that AMS Polymers is currently overvalued in the market.